» Articles » PMID: 409267

Structural Changes in Porcine Xenografts Used As Substitute Cardiac Valves. Gross and Histologic Observations in 51 Glutaraldehyde-preserved Hancock Valves in 41 Patients

Overview
Journal Am J Cardiol
Date 1977 Sep 1
PMID 409267
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Gross and histologic changes are described in 51 Hancock glutaraldehyde-preserved porcine heterograft bioprostheses from 41 patients: 33 valves from 25 patients had been in place for less than 2 months ("early") and 18 valves from 17 patients were examined at later periods up to 75 months ("late") after implantation. The major gross changes were thrombosis (five bioprostheses) and degeneration (three bioprotheses) of the cusps. Major histologic changes observed in 44 bioprostheses (26 early and 18 late) examined histologically were: (1) fibrin deposits on inflow and outflow surfaces of the cusps; (2) inflammatory cell infiltrates; (3) histiocyte deposition; (4) giant cell formation, and (5) focal disruption of the fibrocollagenous structure of the cusps. These observations indicate that porcine bioprostheses are not biologically inert in the human circulation. However, valve failure is rare at the implantation periods studied.

Citing Articles

Age-related enhanced degeneration of bioprosthetic valves due to leaflet calcification, tissue crosslinking, and structural changes.

Xue Y, Kossar A, Abramov A, Frasca A, Sun M, Zyablitskaya M Cardiovasc Res. 2022; 119(1):302-315.

PMID: 35020813 PMC: 10022861. DOI: 10.1093/cvr/cvac002.


Noncalcific Mechanisms of Bioprosthetic Structural Valve Degeneration.

Marro M, Kossar A, Xue Y, Frasca A, Levy R, Ferrari G J Am Heart Assoc. 2021; 10(3):e018921.

PMID: 33494616 PMC: 7955440. DOI: 10.1161/JAHA.120.018921.


Ectopic mineralization in heart valves: new insights from and procalcific models and promising perspectives on noncalcifiable bioengineered valves.

Bonetti A, Marchini M, Ortolani F J Thorac Dis. 2019; 11(5):2126-2143.

PMID: 31285908 PMC: 6588779. DOI: 10.21037/jtd.2019.04.78.


The susceptibility of bioprosthetic heart valve leaflets to oxidation.

Christian A, Lin H, Alferiev I, Connolly J, Ferrari G, Hazen S Biomaterials. 2013; 35(7):2097-102.

PMID: 24360721 PMC: 3937592. DOI: 10.1016/j.biomaterials.2013.11.045.


Tissue-engineered fibrin-based heart valve with a tubular leaflet design.

Weber M, Heta E, Moreira R, Gesche V, Schermer T, Frese J Tissue Eng Part C Methods. 2013; 20(4):265-75.

PMID: 23829551 PMC: 3968886. DOI: 10.1089/ten.TEC.2013.0258.